secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2022-12-19T23:59:59+00:00
Accession:  0001437749-22-029381
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxart appoints Phillip Lee as CFO; interim CFO Fuad Ahmad steps down
---------------------------------------------------------------------

- Phillip Lee appointed CFO, Principal Accounting Officer, and Principal Financial Officer effective Dec 15, 2022.
- Lee previously CFO at Clover Biopharmaceuticals; brings ~15 years biotech finance experience.
- Lee receives $420K base salary, 40% target bonus, option for 412,500 shares, and 68,750 RSUs.
- Fuad Ahmad ceased as Interim CFO on same date.
- Press release issued Dec 19, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774922029381/0001437749-22-029381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774922029381/vxrt20221219_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-029381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer